Assessing the Impact of myHealth Rewards Enrollment Emails
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03965754 |
Recruitment Status :
Completed
First Posted : May 29, 2019
Results First Posted : October 5, 2020
Last Update Posted : December 7, 2020
|
Sponsor:
Geisinger Clinic
Information provided by (Responsible Party):
Amir Goren, Geisinger Clinic
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Observational |
---|---|
Study Design | Observational Model: Case-Control; Time Perspective: Prospective |
Conditions |
Health Promotion Wellness Programs |
Interventions |
Behavioral: Social norms Behavioral: Loss framing Behavioral: Email reminder |
Enrollment | 5697 |
Participant Flow
Recruitment Details | |
Pre-assignment Details |
Arm/Group Title | No Email | Standard Email Reminder | Social Norms Email | Loss Framing |
---|---|---|---|---|
![]() |
No email will be sent out to this subset of GHP members during the week that the other emails are sent. | The standard email reminder mentions the average premium savings, the speed and ease of starting the process, and the deadline for registering and having health measures on file, plus it provides two button links for registering and finding free health screenings where health measures can be collected and registered at one convenient time and location. | The social norms email notes that a majority (78%) of GHP members' colleagues had enrolled in 2018, it provides a testimonial from a medical director at Geisinger's Commonwealth School of Medicine, stating the ways in which myHealth Rewards helped that doctor personally, and it emphasizes the simplicity and ease of taking the first step toward enrollment. | The loss framing email suggests that GHP members are currently "throwing away" a precise dollar amount (over $2,000) by not participating and that they can therefore avoid missing out on substantial gains (i.e., savings) by taking action. |
Period Title: Overall Study | ||||
Started [1] | 1422 | 1425 | 1425 | 1425 |
Completed [2] | 1422 | 1425 | 1425 | 1425 |
Not Completed | 0 | 0 | 0 | 0 |
[1]
No email bounce information was available, so this number includes all people emailed.
[2]
Given no bounce information, all emails were considered received, which we counted as completion.
|
Baseline Characteristics
Arm/Group Title | No Email | Standard Email Reminder | Social Norms Email | Loss Framing | Total | |
---|---|---|---|---|---|---|
![]() |
No email will be sent out to this subset of GHP members during the week that the other emails are sent. | The standard email reminder mentions the average premium savings, the speed and ease of starting the process, and the deadline for registering and having health measures on file, plus it provides two button links for registering and finding free health screenings where health measures can be collected and registered at one convenient time and location. | The social norms email notes that a majority (78%) of GHP members' colleagues had enrolled in 2018, it provides a testimonial from a medical director at Geisinger's Commonwealth School of Medicine, stating the ways in which myHealth Rewards helped that doctor personally, and it emphasizes the simplicity and ease of taking the first step toward enrollment. | The loss framing email suggests that GHP members are currently "throwing away" a precise dollar amount (over $2,000) by not participating and that they can therefore avoid missing out on substantial gains (i.e., savings) by taking action. | Total of all reporting groups | |
Overall Number of Baseline Participants | 1422 | 1425 | 1425 | 1425 | 5697 | |
![]() |
The baseline outcome measure was not applicable, since enrollment and login in response to the email was the outcome. There was no previous email, and participants were selected for not having enrolled in the year of the study period.
|
|||||
Age, Categorical
[1] Measure Type: Count of Participants Unit of measure: Participants |
||||||
Number Analyzed | 1422 participants | 1425 participants | 1425 participants | 1425 participants | 5697 participants | |
<=18 years | NA [2] | NA [2] | NA [2] | NA [2] | NA [3] | |
Between 18 and 65 years | NA [2] | NA [2] | NA [2] | NA [2] | NA [3] | |
>=65 years | NA [2] | NA [2] | NA [2] | NA [2] | NA [3] | |
[1]
Measure Description: Only de-identified data on email engagement was collected; no age data was collected.
[2]
Data not collected
[3]
Total not calculated because data are not available (NA) in one or more arms.
|
||||||
Sex: Female, Male
[1] Measure Type: Count of Participants Unit of measure: Participants |
||||||
Number Analyzed | 1422 participants | 1425 participants | 1425 participants | 1425 participants | 5697 participants | |
Female | NA [2] | NA [2] | NA [2] | NA [2] | NA [3] | |
Male | NA [2] | NA [2] | NA [2] | NA [2] | NA [3] | |
[1]
Measure Description: Only de-identified data on email engagement was collected; no sex or gender data was collected.
[2]
Data not collected
[3]
Total not calculated because data are not available (NA) in one or more arms.
|
||||||
Race and Ethnicity Not Collected
[1] Measure Type: Count of Participants Unit of measure: Participants |
||||||
Number Analyzed | 0 participants | 0 participants | 0 participants | 0 participants | 0 participants | |
0 | ||||||
[1]
Measure Analysis Population Description: Race and Ethnicity were not collected from any participant.
|
||||||
Region of Enrollment
Measure Type: Number Unit of measure: Participants |
||||||
United States | Number Analyzed | 1422 participants | 1425 participants | 1425 participants | 1425 participants | 5697 participants |
1422 | 1425 | 1425 | 1425 | 5697 |
Outcome Measures
Adverse Events
Limitations and Caveats
For this study, we only received data about engagement with the email. Individual patients were not identified and demographic information such as age, sex, or gender were not collected.
More Information
Results Point of Contact
Name/Title: | Amir Goren, PhD |
Organization: | Geisinger Clinic |
Phone: | 5702144395 |
EMail: | agoren@geisinger.edu |
Responsible Party: | Amir Goren, Geisinger Clinic |
ClinicalTrials.gov Identifier: | NCT03965754 |
Other Study ID Numbers: |
2019-0404 |
First Submitted: | May 24, 2019 |
First Posted: | May 29, 2019 |
Results First Submitted: | September 11, 2020 |
Results First Posted: | October 5, 2020 |
Last Update Posted: | December 7, 2020 |